Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Restrict the search for m didanosine to a specific field?

Approximate Matches

2375
Any Name

2361
Standardized Name

1223
Reference Text / Citation

494
Display Name

353
Note

203
Reference URL

146
Related Substance Name

76
Organism Author

68
Relationship Comments

47
Mixture Component Name

30
root_modifications_structuralModifications_molecularFragment_refPname

28
Code Literal

22
Code Comments

17
root_modifications_structuralModifications_residueModified

17
Protein Structural Modification Residue

16
WIKIPEDIA

15
Code URL

9
Structure Stereo Comments

8
ALANWOOD

5
Protein Structural Modification Substance Name

Showing 1131 - 1140 of 4716 results

First page
Previous page
Next page
Next page

Methyl (3Z)-2,3-dihydro-3-[[[4-[methyl[2-(1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-1H-indole-6-carboxylate

3TK2E45UHG

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

(2R)-2-ACETAMIDO-3-HYDROXY-N-((3-HYDROXYPHENYL)METHYL)PROPANAMIDE

4ET5UVK3TL

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

MECOSAR-PHENYLALANINE

WW670WHY6M

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

1H-PYRIDO(4,3-B)INDOL-1-ONE, 2,3,4,5-TETRAHYDRO-7-HYDROXY-5-METHYL-2-((4-METHYL-1H-IMIDAZOL-5-YL)METHYL)-

GMQ9U2S2PG

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

N-ACETYL ALOGLIPTIN

U93RK9Q9H6

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

1H-PYRIDO(4,3-B)INDOL-1-ONE, 2,3,4,5-TETRAHYDRO-6-HYDROXY-5-METHYL-2-((4-METHYL-1H-IMIDAZOL-5-YL)METHYL)-

5Q2P2LRA9J

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

3BETA, 5ALPHA-TETRAHYDROSEGESTERONE ACETATE

F226V6K88Q

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

rel-trans-4-Amino-N-[(1R,2S)-2-phenylcyclopropyl]cyclohexanemethanamine

XC0UT08SNJ

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Lysine-specific histone demethylase 1

Conditions:

Acute myeloid leukemia

Small-cell lung cancer

ORY-1001 (known as RG 6016) is a Lysine Specific Demethylase 1 (LSD1, also known as KDM1A) inhibitor (IC50 <20nM) with high selectivity against related FAD dependent aminoxidases (MAO-A/B, IL4I1, KDM1B >100uM, SMOX 7uM). LSD1 is a histone eraser enzyme that removes methyl groups, specifically mono and demethylated H3K4 and H3K9, and by doing so regulates the expression of many genes important in the onset and progression of diseases such as cancer and neurodegenerative disorders. ORY-1001 is a lead drug candidate of Oryzon Genomics S.A. under development for the treatment of acute myeloid leukemia (AML) – phase I/II and small cell lung cancer (SCLC) – phase I. Oryzon has made significant progress with ORY-1001 over the past years.

N-DEMETHYLCLOBAZAM-3',4'-DIHYDRODIOL

WBC44HTY65

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (UNKNOWN)

3H-PYRAZOL-3-ONE, 2-(3-AMINOPHENYL)-2,4-DIHYDRO-5-METHYL-

Z8G49MH2AF

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

Structure of Methyl (3Z)-2,3-dihydro-3-[[[4-[methyl[2-(1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-1H-indole-6-carboxylate

ACHIRAL

Methyl (3Z)-2,3-dihydro-3-[[[4-[methyl[2-(1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-1H-indole-6-carboxylate

Structure of (2R)-2-ACETAMIDO-3-HYDROXY-N-((3-HYDROXYPHENYL)METHYL)PROPANAMIDE

ABSOLUTE

(2R)-2-ACETAMIDO-3-HYDROXY-N-((3-HYDROXYPHENYL)METHYL)PROPANAMIDE

Structure of MECOSAR-PHENYLALANINE

ABSOLUTE

MECOSAR-PHENYLALANINE

Structure of 1H-PYRIDO(4,3-B)INDOL-1-ONE, 2,3,4,5-TETRAHYDRO-7-HYDROXY-5-METHYL-2-((4-METHYL-1H-IMIDAZOL-5-YL)METHYL)-

ACHIRAL

1H-PYRIDO(4,3-B)INDOL-1-ONE, 2,3,4,5-TETRAHYDRO-7-HYDROXY-5-METHYL-2-((4-METHYL-1H-IMIDAZOL-5-YL)METHYL)-

Structure of N-ACETYL ALOGLIPTIN

ABSOLUTE

N-ACETYL ALOGLIPTIN

Structure of 1H-PYRIDO(4,3-B)INDOL-1-ONE, 2,3,4,5-TETRAHYDRO-6-HYDROXY-5-METHYL-2-((4-METHYL-1H-IMIDAZOL-5-YL)METHYL)-

ACHIRAL

1H-PYRIDO(4,3-B)INDOL-1-ONE, 2,3,4,5-TETRAHYDRO-6-HYDROXY-5-METHYL-2-((4-METHYL-1H-IMIDAZOL-5-YL)METHYL)-

Structure of 3BETA, 5ALPHA-TETRAHYDROSEGESTERONE ACETATE

ABSOLUTE

3BETA, 5ALPHA-TETRAHYDROSEGESTERONE ACETATE

Structure of rel-trans-4-Amino-N-[(1R,2S)-2-phenylcyclopropyl]cyclohexanemethanamine

ABSOLUTE

rel-trans-4-Amino-N-[(1R,2S)-2-phenylcyclopropyl]cyclohexanemethanamine

Structure of N-DEMETHYLCLOBAZAM-3',4'-DIHYDRODIOL

UNKNOWN

N-DEMETHYLCLOBAZAM-3',4'-DIHYDRODIOL

Z8G49MH2AF
Not a public record

Structure of 3H-PYRAZOL-3-ONE, 2-(3-AMINOPHENYL)-2,4-DIHYDRO-5-METHYL-

ACHIRAL

3H-PYRAZOL-3-ONE, 2-(3-AMINOPHENYL)-2,4-DIHYDRO-5-METHYL-

Showing 1131 - 1140 of 4716 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1